Considerations in Adapting Clinical Trial Design
نویسندگان
چکیده
منابع مشابه
Metabolic Syndrome: Important Considerations in Trial Design
Metabolic Syndrome (also referred to as Insulin Resistance Syndrome, Syndrome X, and the Deadly Quartet) is diagnosed by several combined risk factors, and is most notably defined by its patients’ pro-inflammatory state. Metabolic syndrome identifies a cluster of symptoms affecting multiple organs and systems, most importantly the cardiovascular and sugar metabolism systems. Frequent symptoms i...
متن کاملProceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design.
Felix Mahfoud1*, Michael Böhm1, Michel Azizi2,3,4, Atul Pathak5, Isabelle Durand Zaleski6, Sebastian Ewen1, Kostantinos Tsioufis7, Bert Andersson8, Peter J. Blankestijn9, Michel Burnier10, Gilles Chatellier2,11, Sameer Gafoor12,13, Guido Grassi14, Michael Joner15, Sverre E. Kjeldsen16,17, Thomas Felix Lüscher18, Melvin D. Lobo19, Chaim Lotan20, Gianfranco Parati21, Josep Redon22, Luis Ruilope23...
متن کاملClinical trial design in oncology: protocol design.
The protocol describes the objectives, design, methods, statistics, and organisation of the trial, as well as its background and aims—a good trial protocol addresses an important unanswered question. The type and phase of a clinical trial defines many specific parts of the protocol: clinical trials that include surgery or radiotherapy need indepth explanation of the procedures for quality assur...
متن کاملConsiderations unique to pediatrics for clinical trial design in hospital-acquired pneumonia and ventilator-associated pneumonia.
Background. A need exists for new antimicrobial agents to treat neonates, infants, and children for hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) caused by nosocomial antibiotic-resistant pathogens. Current and clear guidance on approval of new agents for all pediatric age groups is lacking. Methods. Studies on HAP and VAP in the neonatal and pediatric age groups w...
متن کاملEquipoise: ethical, scientific, and clinical trial design considerations for compatible pair participation in kidney exchange programs.
Compatible living donor/recipient pair participation (CPP) in kidney exchange (KE) transplantation may substantially increase transplant volumes and significantly mitigate the O blood group donor shortage in KE. Initial ethical analysis did not support CPP for two primary reasons: (1) KE would be "unbalanced," and (2) the possibility of undue influence experienced by the compatible pair living ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the Formosan Medical Association
سال: 2008
ISSN: 0929-6646
DOI: 10.1016/s0929-6646(09)60004-8